Authors' reply
- PMID: 36461802
- DOI: 10.25259/IJDVL_858_2022
Authors' reply
Comment on
-
Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomized, double-blind and placebo-controlled study.Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(4):500-508. doi: 10.25259/IJDVL_565_20. Indian J Dermatol Venereol Leprol. 2022. PMID: 34672473 Clinical Trial.
References
-
- Patra AC, Sil A, Ahmed SS, Rahaman S, Mondal N, Roy S, et al. Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomized, double-blind and placebo-controlled study. Indian J Dermatol Venereol Leprol. 2022; 88:500-8
-
- Monteiro RC, Shetty P, Marne RB, Mysore V, Patil SR,. Letter to the editor regarding “Effectiveness and safety of 0.5% timolol solution in the treatment of pyogenic granuloma: A randomised, double-blind and placebo-controlled study”. Indian J Dermatol Venereol Leprol. 2023; 89:7610.25259/IJDVL_754_2022 36461800
-
- Gupta D, Singh N, Thapa DM,. Is timolol an effective treatment for pyogenic granuloma?. Int J Dermotol. 2016; 55:592-5
Publication types
LinkOut - more resources
Full Text Sources
